HI Health In Tech, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Track the Health In Tech, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Health In Tech, Inc. has recorded 36 insider filings. Market capitalisation: €65.9m. The latest transaction was filed on 17 August 2026 (Retenue fiscale). Among the most active insiders: Johnson Tim Donald. The full history is accessible without an account.
Analyst consensus: bullish or bearish? Analysts rate Health In Tech, Inc. Strong Buy (bullish), based on 3 analysts. Average price target: US$3.70.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,588 of 29,062 companies
FCF yld -0.1%
Earn yld 2.0%
EV/EBITDA 25.0x
ROE -22%
Gross mgn 63%
Net mgn 3.8%
Debt/EBITDA 0.1x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 August 2026
All Executives36 Thresholds0 Prospectus0 Other0
Declarations 36 total
● Chief Growth Officer · Executives · 13 Aug 2026
4,007 shares @ US$1.06 Class A Common Stock SEC:0001213900-26-090790:0
● Chief Executive Officer · Executives · 13 Aug 2026
46,327 shares @ US$1.06 Class A Common Stock SEC:0001213900-26-090793:0
● Chief Financial Officer · Executives · 13 Aug 2026
28,183 shares @ US$1.06 Class A Common Stock SEC:0001213900-26-090796:0
● Chief Financial Officer · Executives · 15 Jul 2026
28,725 shares @ US$1.04 0.043% mcap 48.9% of flow Class A Common Stock SEC:0001213900-26-079323:0
● Chief Growth Officer · Executives · 15 Jul 2026
4,084 shares @ US$1.04 0.0061% mcap 45.9% of flow Class A Common Stock SEC:0001213900-26-079326:0
● Chief Executive Officer · Executives · 15 Jul 2026
47,217 shares @ US$1.04 0.070% mcap 49.0% of flow Class A Common Stock SEC:0001213900-26-079324:0
◆ Director · Executives · 8 Jul 2026
18,867 shares @ US$1.06 0.029% mcap 17.2% of flow Class A Common Stock SEC:0001213900-26-077301:0
◆ Director · Executives · 8 Jul 2026
18,867 shares @ US$1.06 0.029% mcap 17.2% of flow Class A Common Stock SEC:0001213900-26-077302:0
◆ Director · Executives · 8 Jul 2026
18,867 shares @ US$1.06 0.029% mcap 17.2% of flow Class A Common Stock SEC:0001213900-26-077303:0
● Chief Executive Officer · Executives · 15 Apr 2026
35,140 shares @ US$1.50 0.049% mcap 50.0% of flow Class A Common Stock SEC:0001213900-26-045741:0
● Chief Executive Officer · Executives · 15 Apr 2026
35,140 shares @ US$1.50 0.080% mcap 33.3% of flow Class A Common Stock SEC:0001213900-26-045210:0
● Chief Growth Officer · Executives · 15 Apr 2026
3,448 shares @ US$1.50 0.0078% mcap 100.0% of flow Class A Common Stock SEC:0001213900-26-045214:0
● Chief Financial Officer · Executives · 15 Apr 2026
21,480 shares @ US$1.50 0.049% mcap 100.0% of flow Class A Common Stock SEC:0001213900-26-045212:0
◆ General Counsel · Executives · 10 Apr 2026
5,000 shares 0Class A Common Stock SEC:0001213900-26-043124:0
◆ Director · Executives · 8 Apr 2026
13,598 shares @ US$1.36 100.0% of flow Class A Common Stock SEC:0001213900-26-042698:0
◆ Director · Executives · 8 Apr 2026
13,598 shares @ US$1.36 100.0% of flow Class A Common Stock SEC:0001213900-26-042696:0
◆ Director · Executives · 8 Apr 2026
13,598 shares @ US$1.36 100.0% of flow Class A Common Stock SEC:0001213900-26-042697:0
◆ Chief Growth Officer · Executives · 6 Jan 2026
200,000 shares 0Class A Common Stock SEC:0001213900-26-002660:0
◆ Chief Executive Officer · Executives · 6 Jan 2026
1,000,000 shares 0Class A Common Stock SEC:0001213900-26-002659:0
◆ Chief Financial Officer · Executives · 6 Jan 2026
1,000,000 shares 0Class A Common Stock SEC:0001213900-26-002658:0
◆ CISO · Executives · 5 Nov 2025
8,000 shares 0Class A Common Stock SEC:0001213900-25-107767:0
● Director · Executives · 3 Oct 2025
28,159 shares 0Class A Common Stock SEC:0001213900-25-098194:0
● Director · Executives · 3 Oct 2025
65,469 shares 0Class A Common Stock SEC:0001213900-25-098192:0
● Director · Executives · 3 Oct 2025
28,159 shares 0Class A Common Stock SEC:0001213900-25-098193:0
◆ Chief Executive Officer · Executives · 24 Sept 2025
80,000 shares 0Class A Common Stock SEC:0001213900-25-093326:0
25 of 36 declarations
Load more (11 remaining) 关于 Health In Tech, Inc. Health In Tech, Inc.(股票代码:HIT)是一家在美国纽约证券交易所/纳斯达克市场上市的美国保险科技公司,在美国内华达州注册成立。公司总部位于佛罗里达州斯图尔特,致力于将健康保险与技术相结合,其商业模式专注于简化、自动化和加速自保型健康计划及相关保险解决方案的销售和服务流程。根据其美国证券交易委员会(SEC)备案文件,HIT于2021年11月注册成立,旨在将数家独立业务整合为单一运营结构,包括Stone Mountain Risk (SMR)、Health Intelligence Card (Hi Card) 和 International Captive Exchange (ICE)。([sec.gov](https://www.sec.gov/Archives/edgar/data/0002019505/000121390026034211/ea0283147-10k_health.htm?utm_source=openai))
运营方面,Health In Tech 将自身描述为一个由人工智能驱动的保险技术平台和市场,旨在通过垂直整合、流程简化和自动化来改进医疗保健行业的流程。其专有的eDIYBS平台旨在简化大型雇主自保型健康计划和中小型企业分级资助计划的报价和绑定流程。HIT主要服务于经纪人、第三方管理机构(TPA)、承运商和管理总承保人(MGU),这使其更接近于一个技术赋能的分销和工作流平台,而非传统的承运商。([sec.gov](https://www.sec.gov/Archives/edgar/data/2019505/000121390026047605/ea0287599-s3_health.htm?utm_source=openai))
从竞争角度来看,该公司的价值主张集中于减少复杂、分散且行政管理密集的美国健康福利市场中的销售周期摩擦。HIT表示其业务遍及美国全部50个州,使其拥有全国性的覆盖范围,尽管其公司基地和管理职能集中在佛罗里达州。其核心产品包括自保型健康计划赋能、报价和绑定工作流、通过Stone Mountain Risk提供的止损解决方案,以及拓宽平台范围的辅助产品线,包括重疾险、意外险、牙科险、视力险、定期寿险和GAP保险。([healthintech.com](https://healthintech.com/about/?utm_source=openai))
近期发展表明公司正积极推进增长和资本市场议程。在SEC备案文件和公司通讯中,HIT强调了商业扩张、新增辅助产品以及品牌建设举措,例如其2026年的hitDavos活动。公司还披露了2026年3月的PIPE融资,并成为Form 4内部人交易备案的主体,这突显了持续的股东活动和市场关注。对于投资者而言,HIT应被视为一家在美国纳斯达克上市的小型保险科技公司,具有进攻性增长特征,受益于自保型医疗计划的扩张,但也面临执行风险、商业依赖性和潜在稀释风险。([sec.gov](https://www.sec.gov/Archives/edgar/data/2019505/000121390026034716/ea0283456-8k_health.htm?utm_source=openai))